Effectiveness and Safety of Acupuncture for Climacteric Syndrome in Patients With Breast Cancer
- Conditions
- Climacteric Syndrome
- Registration Number
- NCT01275807
- Lead Sponsor
- Azienda Usl di Bologna
- Brief Summary
The purpose of the investigators study is to create the evidence of effectivness on climacteric syndrome in patients affected by breast cancer, by acupuncture added to the standard care (self care).
- Detailed Description
The study will be performed under randomized, open, controlled design. The effect of acupuncture and control group will be compared including the following outcomes: Greene climacteric scale score, quality of life (MenQol italian version), overall improvement in climacteric syndrome, adverse effects from treatment.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 190
- breast cancer
- thermoregulation symptoms from at least 6-8 weeks - at least 6 hot flushes a day
- climateric simptoms
- age from 18 to 65 years
- spontaneous or caused by chemotherapy amenorrea
- hormone therapy for breast cancer
- Green climateric scale score = or > of 15
- performance status Eastern Cooperative Oncology Group (ECOG) < or = to 1
- the patient agrees to follow physical exercice
- diet and self-help groups
- Hormone substitutive Therapy (TOS) during the last month
- other systemic treatments for climateric syndrome (tibolone, antidepressants, homeopathy)
- chemotherapy or radiotherapy
- patients who refuses acupuncture
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Greene climacteric scale baseline ( 14 days before randomization) , between the 5th and 6th session af acupunture(only for experimental arm) at 14 weeks after randomization and at 3 and at 6 month after randomization for both arms. Greene's score as measure for severity of menopausal symptoms. Change in the number of hot flashes.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (4)
Oncologic Medicine, Carpi Hospital
🇮🇹Carpi, Modena, Italy
Unità operativa (U.O.) salute donna infanzia e adolescenza e Unità operativa Consultori
🇮🇹Bologna, Italy
Dipartimento Anestesia, rianimazione, terapia del dolore e comparto operatorio,
🇮🇹Piacenza, Italy
U.O. Medicina Oncologica - Ospedale Santa Maria Nuova Reggio Emilia
🇮🇹Reggio Emilia, Italy
Oncologic Medicine, Carpi Hospital🇮🇹Carpi, Modena, Italy